Gover Justin D.
SEC insider (Form 3/4/5 filer). CIK 0001754129. Director at Design Therapeutics, Inc. (DSGN) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in BURNABY.
Companies Gover Justin D. has filed insider reports for
- Design Therapeutics, Inc. (DSGN): Director
- Xenon Pharmaceuticals Inc. (XENE): Director
- COMPASS Pathways plc (CMPS): Director
Gover Justin D.
CIK: 0001754129
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 9, 2026DSGN
Design Therapeutics, Inc.
AwardDirectStock Option (right to buy)
30K shares- - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
10.5K shares- - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
1.6K shares- - Jun 1, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect2.6K shares- - May 27, 2026CMPS
COMPASS Pathways plc
AwardDirectShare Option (Right to Buy)
21.1K shares- - Jan 2, 2026DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
45K shares- - Sep 9, 2025DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
15.8K shares- - Sep 9, 2025DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
30K shares- - Jul 29, 2025CMPS
COMPASS Pathways plc
AwardDirectShare Option (Right to Buy)
52K shares- - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
17K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  DSGN Design Therapeutics, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jun 3, 2026 |  XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 10,507 | - | - | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 1,593 | - | - | Direct |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 2,645 | - | $0 | Direct |
| May 27, 2026 |  CMPS COMPASS Pathways plc | Award Share Option (Right to Buy) | 21,110 | - | - | Direct |
| Jan 2, 2026 | DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 45,000 | - | - | Direct |
| Sep 9, 2025 | DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 15,833 | - | - | Direct |
| Sep 9, 2025 | DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 30,000 | - | - | Direct |
| Jul 29, 2025 | CMPS COMPASS Pathways plc | Award Share Option (Right to Buy) | 52,000 | - | - | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 17,012 | - | - | Direct |
1-10 of 11 transactions